An interventional study of Augumented Reality-Based Training and Sensory-Integration Therapy in Autism Spectrum Disorder, sponsored by Riphah International University. Not yet recruiting at 1 site in Pakistan. Open to participants aged 4 Years to 10 Years. Per ClinicalTrials.gov, last updated 2026-11-06.
Sponsored by Riphah International University · Not applicable, Interventional, and Treatment
To determine and contrast the effects of Sensory Integration Therapy (SIT) and Augmented Reality-Based Training (AR) on gross motor skills, assessed using the Test of Gross Motor Development-Third Edition (TGMD-3), in children with Autism Spectrum Disorder. To assess the impact of Sensory Integration Therapy and Augmented Reality-Based Training on balance, measured using the Pediatric Balance Scale (PBS), and determine which intervention yields superior outcomes in children with Autism Spectrum Disorder.To examine post-intervention Short Sensory Profile (SSP) scores between the two treatments groups following 8 weeks of intervention, in order to identify differential improvements in sensory processing. To determine changes in autism severity, using the Childhood Autism Rating Scale (CARS), from baseline to post-intervention, and to analyze whether Sensory Integration Therapy or Augmented Reality Based Training results in greater improvement.
1,724 studies on the registry are indexed under Autism Spectrum Disorder; 500 are open to participants now.
This study's planned enrollment of 32 is below the median of 52 across 1,368 interventional studies indexed under Autism Spectrum Disorder.
Browse Autism Spectrum Disorder studies →Riphah International University is the lead sponsor of 2,193 studies on the registry; 650 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Other: Augumented Reality-Based Training
Other: Sensory-Integration Therapy
The experimental will receive Augmented Reality (AR)-based training involving interactive virtual reaching, stepping, locomotor, and balance exercises with real-time visual and auditory feedback. In both groups, the intervention intensity and task complexity will be progressively increased throughout the 8-week program to optimize improvements in gross motor skills and balance.
Participants in both groups will receive supervised interventions 3 times per week for eight weeks (24 sessions), with each session lasting 45-60 minutes, including a 5-minute warm-up, 35-50 minutes of intervention, and a 5minute cool-down. The control group will receive conventional Sensory Integration-Therapy (SIT), comprising vestibular, tactile, gross motor, and balance activities with progressive therapist-guided difficulty over the period of 8 weeks.
Test of Gross Motor Development-Third Edition
To compare the effects of sensory integration therapy and augmented reality-based training on gross motor skills using TGMD-3. According to the TGMD-3 scoring guidance, each performance criterion receives 0 or 1 point. The assessment includes 13 skills, with six locomotor skills and seven ball skills.
Time frame: 8 weeks
Pediatric Balance Scale
14-item scale assessing static and dynamic balance. Measured at baseline and post-intervention.The PBS assesses functional balance in children through 14 tasks. Each task is scored from 0 to 4, giving a maximum total score of 56.
Time frame: 8 weeks
Short Sensory Profile
The Short Sensory Profile (SSP) is a 38-item caregiver questionnaire used to identify sensory processing difficulties in children with ASD . Each item is scored from 1 to 5, giving a total score ranging from 38 to 190.
Time frame: 8 weeks
Childhood Autism Rating Scale
The Childhood Autism Rating Scale (CARS) is used to assess autism-related behaviors and help determine the severity of autism-related characteristics.Each item is scored from 1 to 4, using half-point increments when appropriate. There are 15 items, so the total score ranges from 15 to 60.
Time frame: 8 weeks
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Nov 2026; primary completion for Jun 2027, 7 months later.
Of 800 non-industry interventional studies with no phase under Autism Spectrum Disorder, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 48. This study's planned 7 months is below that.
Counting every sponsor, half of 823 studies reached it within 25 months; a quarter within 12 and three quarters within 47.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Riphah International University →